Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density

References

• Barrett-Connor E, Grady D, Stefanick M L. The rise and fall of menopausal hormone therapy. Annu Rev Public Health 2005; 26: 115–140
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Chlebowski R T, Hendrix S L, Langer R D, et al. WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003; 289: 3243–3253
   PubMed Web of Science ®Google Scholar
• Beral V. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419–427
   PubMed Web of Science ®Google Scholar
• Stefanick M L, Anderson G L, Margolis K L, et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006; 295: 1647–1657
   PubMed Web of Science ®Google Scholar
• Druckmann R. Progestins and their effects on the breast. Maturitas 2003; 46: 56–69
   Google Scholar
• Miller W R, Langdon S P. Steroid hormones and cancer. III. Lessons from experimental systems. Eur J Surg Oncol 1997; 23: 163–177
   PubMedGoogle Scholar
• Boyd N F, Rommens J M, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005; 6: 798–808
   PubMed Web of Science ®Google Scholar
• Warren R. Hormones and mammographic breast density. Maturitas 2004; 49: 67–78
   PubMed Web of Science ®Google Scholar
• Boyd N F, Guo H, Martin L J, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227–236
   PubMed Web of Science ®Google Scholar
• Lundström E, Wilczek B, von Palffy Z, et al. Mammographic breast density during hormone replacement therapy: differences according to treatment. Am J Obstet Gynecol 1999; 181: 348–352
   PubMed Web of Science ®Google Scholar
• Greendale G A, Reboussin B A, Sie A, et al. Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/ Progestin Interventions (PEPI) Investigators. Ann Intern Med 1999; 130: 262–269
   PubMed Web of Science ®Google Scholar
• Lundström E, Christow A, Kersemaekers W, et al. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol 2002; 186: 717–722
   PubMed Web of Science ®Google Scholar
• Conner P, Svane G, Azavedo E, et al. Mammographic breast density, hormones and growth factors during continuous combined hormone therapy. Fertil Steril 2004; 81: 1617–1623
   PubMed Web of Science ®Google Scholar
• Panay N, Ylikorkala O, Archer D F, et al. Ultra-low-dose estradiol and norethisterone acetate: effective menopause symptom relief. Climacteric 2007; 10: 120–131
   PubMed Web of Science ®Google Scholar
• Lundström E, Wilczek B, von Palffy Z, et al. Mammographic breast density during HRT: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens. Climacteric 2001; 4: 42–48
   PubMedGoogle Scholar
• Wolfe J N. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976; 26: 1130–1139
   Google Scholar
• Byng J W, Boyd N F, Jong R A, et al. Quantitative analysis of mammographic parenchymal densities. Phys Med Biol 1994; 39: 1629–1638
   PubMed Web of Science ®Google Scholar
• Byng J W, Boyd N F, Fishell E, et al. Automated analysis of mammographic densities. Phys Med Biol 1996; 41: 909–923
   PubMed Web of Science ®Google Scholar
• Lundström E, Söderqvist G, Svane G, et al. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate; a pilot study. Fertil Steril 2006; 85: 989–995
   PubMed Web of Science ®Google Scholar
• Vachon C M, Brandt K R, Ghosh K, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 43–49
   PubMed Web of Science ®Google Scholar
• Boyd N F, Lockwood G A, Martin L J, et al. Mammographic density as a marker of susceptibility to breast cancer: a hypothesis. IARC Sci Publ 2001; 154: 163–169
   PubMedGoogle Scholar
• Boyd N F, Stone J, Martin L J, et al. The association of breast mitogens with mammographic densities. Br J Cancer 2002; 87: 876–882
   PubMed Web of Science ®Google Scholar
• Conner P. Breast response to menopausal hormone therapy – aspects on proliferation, apoptosis and mammographic density. Ann Med 2007; 39: 28–41
   PubMed Web of Science ®Google Scholar
• Conner P, Söderqvist G, Skoog L, et al. Breast cell proliferation in postmenopausal women during HRT evaluated through fine needle aspiration cytology. Breast Cancer Res Treat 2003; 78: 159–165
   PubMed Web of Science ®Google Scholar
• Hofling M, Lundström E, Azavedo E, et al. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density. Climacteric 2007; 10: 155–163
   PubMed Web of Science ®Google Scholar
• Lundström E, Sahlin L, Skoog L, et al. Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density. Climacteric 2006; 9: 277–282
   PubMed Web of Science ®Google Scholar
• Alowami S, Troup S, Al-Haddad S, et al. Mammographic density is related to stroma and stromal proteogycan expression. Breast Cancer Res 2003; 5: 129–135
   PubMed Web of Science ®Google Scholar
• Imagawa W, Pedchenko V K, Helber J, et al. Hormone/growth factors interactions mediating epitelial/stromal communication in mammary gland development and carcinogenesis. J Steroid Biochem Mol Biol 2002; 80: 213–230
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. Position Statement on Estrogen and Progestogen use in peri- and postmenopausal women. Menopause 2007; 14: 168–182
   PubMed Web of Science ®Google Scholar
• EMEA Public Statement on Recent Publications Regarding Hormone Replacement Therapy, Available at: http://www.emea.eu.int/pdfs/human/press/pus/3306503en.pdf (accessed October 13, 2005)
   Google Scholar
• Peeyananjarassri K, Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 2005; 8: 13–23
   PubMed Web of Science ®Google Scholar
• Grady D, Vittinghoff E, Lin F, et al. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women. Menopause 2007, Jan 11, Epub ahead of print
   PubMed Web of Science ®Google Scholar